AnaptysBio Shares Fall 7.74% During GSK-Tesaro Post-Trial Hearing

GSK’s U.S. depositary shares closed 2.37% higher on Oct. 20. A ruling in the Jemperli rights dispute is expected by early 2027.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.